SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Geronimo — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeronimo
Date of birth1829-06-01
IdentifiersMRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729
Document date1906-08-19
AuthorRoberta Whitehorse-Lindgren, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review: therapy, naltrexone, sleep and mood. [S]

History of Present Illness

Geronimo returns six weeks after intake, with the interpreter. He has had four sessions of cognitive processing therapy and says the therapist listens and does not push him to speak of what he will not. He drinks on two evenings a week, two drinks each time, and has had no nausea on naltrexone. The nightmares still come about four nights a week and he sleeps four or five hours. He asks whether a medicine could help him sleep and lift the heaviness. Sertraline was explained, with its side effects and the sodium check, and prazosin for nightmares was discussed: he chose sertraline at a low dose and agreed to wait on prazosin because of his fall. [S]

ElementDetail
TherapyFour of twelve sessions
DrinkingTwo evenings a week, two drinks each
PCL-546
PHQ-910, item 9 scored 0
Liver testsAST 41, ALT 31, GGT 84 U/L

Review of Systems

SystemResultFinding
PsychiatricPositiveNightmares four nights a week; mood heavy; no thoughts of suicide
GastrointestinalNegativeNo nausea or abdominal pain on naltrexone
NeurologicalNegativeNo dizziness on standing

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1906-07-08activeS
Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicinesOne tablet dailyOral route1906-07-22activeS
Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium checkOne tablet each morningOral route1906-08-19 to 1906-09-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1906-08-19Body height173cmS
1906-08-19Body weight66.8kgS
1906-08-19Body mass index (BMI) [Ratio]22.3kg/m2S
1906-08-19Systolic blood pressure132mm[Hg]S
1906-08-19Diastolic blood pressure78mm[Hg]S
1906-08-19Heart rate74/minS
1906-08-19Respiratory rate16/minS
1906-08-19Body temperature36.6CelS
1906-08-19Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1906-08-19PTSD PCL-5 score [PCL-5]46{score}S
1906-08-19Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S
1906-08-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma41U/L10-40 U/LHighS
1906-08-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-56 U/LNormalS
1906-08-19Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma84U/L8-61 U/LHighS

Physical Exam

Vital signs recorded on 1906-08-19; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 132/78 seated and 130/76 standing; pulse 74; weight 66.8 kg
Mental statusCalm; more eye contact; mood heavy; no thoughts of suicide or of harming anyone
GaitSteady; Timed Up and Go 12 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessedresolvedconfirmed G47.00S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep.
Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not metactiveconfirmed F43.12S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person.
Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinkingactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking.
A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 secondsactiveconfirmed Z91.81S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPTSD symptom severity (PCL-5)Baseline, then every visit during treatmentCompleted today46, from 56
Self-managementTrauma-focused psychotherapy (cognitive processing therapy), sessions attendedWeekly for twelve sessionsCompleted todayFour of twelve sessions attended
SurveyDepressive symptoms (PHQ-9)Baseline, then monthly during active treatmentCompleted today10, from 11; item 9 scored 0
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; 988 card carried; sertraline dispensed four weeks at a time
Self-managementDrinking since the last visit, against his own goalEvery visitCompleted todayTwo evenings a week, two drinks each
LaboratoryLiver tests (AST, ALT, GGT) on naltrexoneBefore starting, at four to six weeks, then every three to six monthsCompleted todayAST 41, ALT 31, GGT 84 U/L, four weeks on naltrexone
LaboratoryPEth, a blood marker of drinking over the past two to four weeksAt baseline and every one to three months during treatment, with consentUp to dateDue at the next visit
Medication safetyNaltrexone safety: opioid use, nausea, wallet cardEvery visitCompleted todayNo opioid use; no nausea
Medication safetySSRI safety: sodium, bleeding, falls and side effectsSodium within the first month in older adults; review at each dose changeOrderedSertraline 25 mg started today; sodium due in two to four weeks
Medication safetyPrazosin for nightmaresWhen nightmares persist despite first-line treatmentNot indicatedNot started now: orthostatic falls risk in a man of 77 who fell recently; reconsider after therapy and sertraline
ExaminationFalls and gait (Timed Up and Go), orthostatic blood pressureAt intake and every visit after a fallCompleted todayTimed Up and Go 12 seconds; standing pressure 130/76; no falls
Self-managementTraditional healing alongside clinic care, at his choiceEvery visitCompleted todayHis choice; nothing asked

Goal progress:

Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)

Follow-up: Sodium in two to four weeks. Eleven-week review with PEth and liver tests. Therapy weekly. Call the clinic or 988 at any hour. Next scheduled visit 1906-09-23: eleven-week review: therapy progress, sertraline and sodium, drinking and falls. [S]